Jaime Bartushak

Director of Finance/CFO at CITIUS PHARMACEUTICALS, INC.

Net worth: 659 931 $ as of 2026-05-30

59 year

Health Technology

Consumer Services

Profile

Jaime Bartushak is the founder.
Mr. Bartushak was the Chief Financial Officer at Leonard-Meron Biosciences, Inc. since 2014.
Mr. Bartushak is the CFO, Chief Accounting & Business Officer at Citius Pharmaceuticals, Inc. since 2022.
Mr. Bartushak is the Chief Financial Officer & Treasurer at Citius Oncology, Inc. since 2024.
Education includes undergraduate and graduate degrees from New Jersey Institute of Technology.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
0.89%	2025-09-18	825,000 ( 0.89% )	658 350 $	2026-05-30
CITIUS PHARMACEUTICALS INC 0.01%	2026-02-12	2,414 ( 0.01% )	1 581 $	2026-05-30

Jaime Bartushak active positions

Companies	Position	Start
CITIUS PHARMACEUTICALS, INC.	Director of Finance/CFO	2017-11-26

All active positions of Jaime Bartushak

Former positions of Jaime Bartushak

Companies	Position	End
Leonard-Meron Biosciences, Inc. Leonard-Meron Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical company that develops and commercializes critical care products	Founder	2017-10-31

See the detail of Jaime Bartushak's experience

Training of Jaime Bartushak

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jaime Bartushak's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Citius Pharmaceuticals, Inc. Citius Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Operates as a pharmaceutical company	Health Technology
New Jersey Institute of Technology New Jersey Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Leonard-Meron Biosciences, Inc. Leonard-Meron Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceutical company that develops and commercializes critical care products	Health Technology